|  Download for Citation Managers
BRIEF COMMUNICATION
Indian subset analysis of a phase iiib open-label study of afatinib in epidermal growth factor receptor tyrosine kinase inhibitor-naïve patients with epidermal growth factor receptor mutation positive non-small cell lung cancer
Rajappa Senthil J, Srinivasa B J, Bondarde Shailesh A, Gokhale Partha Mohan, Sonone Pankaj, Dahiya Arun Kumar
Year : 2021 | Volume: 5 | Issue Number: 3 | Page: 116-118
Click here to read this article
|
| |
|
